UnitedHealth Group Incorporated $UNH Shares Sold by Truist Financial Corp

Truist Financial Corp lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 32.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 395,178 shares of the healthcare conglomerate’s stock after selling 189,257 shares during the quarter. Truist Financial Corp’s holdings in UnitedHealth Group were worth $123,284,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Emerald Advisors LLC increased its stake in UnitedHealth Group by 19.4% during the second quarter. Emerald Advisors LLC now owns 1,089 shares of the healthcare conglomerate’s stock worth $340,000 after acquiring an additional 177 shares during the last quarter. Bluesphere Advisors LLC purchased a new position in UnitedHealth Group in the second quarter valued at approximately $485,000. Sterling Investment Advisors Ltd. grew its stake in UnitedHealth Group by 18.1% during the second quarter. Sterling Investment Advisors Ltd. now owns 680 shares of the healthcare conglomerate’s stock worth $212,000 after buying an additional 104 shares during the period. Summit Financial Strategies Inc. lifted its holdings in shares of UnitedHealth Group by 23.8% during the 2nd quarter. Summit Financial Strategies Inc. now owns 1,754 shares of the healthcare conglomerate’s stock valued at $547,000 after acquiring an additional 337 shares in the last quarter. Finally, Asio Capital LLC increased its holdings in UnitedHealth Group by 31.0% in the 2nd quarter. Asio Capital LLC now owns 20,440 shares of the healthcare conglomerate’s stock valued at $6,377,000 after purchasing an additional 4,841 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $345.11 on Wednesday. The company has a market cap of $312.56 billion, a PE ratio of 14.95, a P/E/G ratio of 2.25 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a fifty day moving average price of $303.65 and a two-hundred day moving average price of $357.64. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same period last year, the firm posted $6.80 earnings per share. The company’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group’s payout ratio is currently 38.30%.

Analyst Ratings Changes

A number of research firms have recently issued reports on UNH. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Truist Financial boosted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a report on Tuesday, September 9th. Finally, Sanford C. Bernstein lifted their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.